Skip to main content
    D

    DaVita HealthCare Partners Inc (DVA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $174.14
    -0.42 (-0.24%)

    Market Cap: $10.98B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    DaVita HealthCare Partners Inc (DVA) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    DaVita HealthCare Partners reported revenue of $13.64B for the fiscal year ended Dec 31, 2025, up 6.5% from the year before. That year, net income was $1.08B with a net margin of 7.9%, operating cash flow was $1.89B and free cash flow was $1.31B. The quarter ended Sep 30, 2026 had revenue of $3.58B and net income of $269.39M.

    Revenue and Margins

    The operating margin was 15.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $11.14B, a compound annual rate of 2.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$13.64B+6.5%32.2%15.0%7.9%
    Dec 2024$12.82B+5.6%32.9%16.3%9.8%
    Dec 2023$12.14B+4.6%31.5%13.2%7.9%
    Dec 2022$11.61B-0.1%29.3%11.5%6.7%
    Dec 2021$11.62B+0.6%31.4%15.5%10.4%
    Dec 2020$11.55B+1.4%30.8%14.7%8.6%
    Dec 2019$11.39B-0.1%30.5%14.4%9.0%
    Dec 2018$11.40B+0.4%28.1%13.4%2.9%
    Dec 2017$11.36B+2.0%28.5%16.0%7.3%
    Dec 2016$11.14BN/A29.3%18.2%9.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 13.6% from the year before. In the quarter ended Sep 2026, net income rose 12.1% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$13.64B$12.82B$12.14B$11.61B$11.62B$11.55B$11.39B$11.40B$11.36B$11.14B
    Cost of revenue$9.24B$8.60B$8.32B$8.21B$7.97B$7.99B$7.91B$8.20B$8.13B$7.87B
    Gross profit$4.40B$4.22B$3.82B$3.40B$3.65B$3.56B$3.47B$3.21B$3.24B$3.26B
    Operating income$2.04B$2.09B$1.60B$1.34B$1.80B$1.69B$1.64B$1.53B$1.81B$2.03B
    Net income$1.08B$1.25B$956.98M$781.64M$1.21B$994.68M$1.02B$333.04M$830.55M$1.03B
    EBITDA$2.66B$2.74B$2.33B$2.06B$2.48B$2.34B$2.29B$2.13B$2.61B$2.76B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$3.58B$3.55B$3.42B$3.62B$3.42B$3.38B$3.22B$3.29B$3.26B$3.19B$3.07B$3.15B
    Gross profit$1.13B$1.16B$1.07B$1.21B$1.09B$1.12B$983.87M$1.07B$1.11B$1.04B$991.58M$1.01B
    Operating income$499.25M$579.00M$481.89M$561.07M$505.77M$537.84M$438.94M$565.36M$534.88M$506.40M$483.85M$389.91M
    Net income$269.39M$343.22M$275.04M$331.03M$240.25M$275.22M$232.22M$349.25M$295.76M$299.75M$305.98M$230.57M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $10.27B exceeded cash and equivalents by $9.60B. Shareholder equity was negative, at -$651.08M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$17.48B$17.29B$16.89B$16.93B$17.12B$16.99B$17.31B$19.11B$18.97B$18.76B
    Current assets$4.06B$3.75B$3.14B$3.16B$3.17B$3.15B$3.69B$8.42B$8.77B$3.99B
    Cash and equivalents$676.44M$794.93M$380.06M$244.09M$461.90M$324.96M$1.10B$323.04M$508.23M$674.78M
    Total liabilities$16.32B$15.19B$14.15B$14.70B$14.75B$14.09B$13.81B$14.08B$13.08B$12.93B
    Short-term debt$109.20M$270.87M$123.30M$231.40M$179.03M$168.54M$130.71M$1.93B$178.21M$160.26M
    Long-term debt$10.16B$9.18B$8.27B$8.69B$8.73B$7.92B$7.98B$8.17B$9.16B$8.94B
    Shareholder equity-$651.08M$121.12M$1.06B$712.33M$755.51M$1.38B$2.13B$3.70B$4.69B$4.65B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$17.82B$17.71B$17.50B$17.48B$17.56B$17.49B$17.12B$17.29B$17.50B$17.03B$17.43B$17.62B
    Total liabilities$16.69B$16.63B$16.45B$16.32B$16.22B$15.94B$15.46B$15.19B$15.28B$14.60B$14.79B$14.88B
    Cash and equivalents$495.63M$668.96M$644.24M$757.75M$705.96M$708.42M$438.78M$794.93M$1.07B$416.49M$345.13M$464.63M
    Shareholder equity-$591.09M-$765.10M-$755.50M$1.16B-$571.87M-$369.63M-$267.10M$2.09B$386.71M$632.90M$926.00M$2.74B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 69.3% of operating cash flow. Dividends and share repurchases together came to 126.7% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$1.89B$2.02B$2.06B$1.56B$1.93B$1.98B$2.07B$1.77B$1.91B$1.97B
    Capital expenditures$575.86M$555.44M$567.99M$603.43M$641.47M$674.54M$766.55M$987.14M$905.25M$829.10M
    Free cash flow$1.31B$1.47B$1.49B$961.14M$1.29B$1.30B$1.31B$784.50M$1.01B$1.14B
    Dividends paid$350.27M$391.00M$293.49M$288.72M$264.14M$260.95M$301.14M$224.52M$216.82M$213.91M
    Share repurchases$1.31B$1.39B$272.22M$802.23M$1.54B$1.46B$2.38B$1.16B$802.95M$1.10B
    Investing cash flow-$654.95M-$771.43M-$771.80M-$630.35M-$784.73M-$825.37M$3.00B-$1.01B-$1.36B-$1.20B
    Financing cash flow-$1.37B-$816.94M-$1.17B-$1.12B-$1.08B-$1.85B-$4.70B-$625.35M-$766.26M-$1.35B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$518.83M$490.07M$320.83M$540.73M$841.53M$324.24M$180.01M$547.63M$810.40M$798.85M-$134.84M$485.20M
    Capital expenditures$159.49M$169.82M$102.02M$145.43M$166.09M$121.09M$143.26M$170.66M$139.05M$124.72M$121.02M$158.97M
    Free cash flow$359.34M$320.25M$218.81M$395.30M$675.44M$203.15M$36.75M$376.97M$671.36M$674.12M-$255.85M$326.23M
    Last 12 quarters

    Frequently Asked Questions About DVA

    What is DaVita HealthCare Partners' annual revenue?

    DaVita HealthCare Partners reported revenue of $13.64B for the fiscal year ended Dec 31, 2025.

    How fast is DaVita HealthCare Partners' revenue growing?

    Revenue was up 6.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.5%.

    Is DaVita HealthCare Partners profitable?

    Yes. DaVita HealthCare Partners reported net income of $1.08B for the fiscal year ended Dec 31, 2025, with a net margin of 7.9%.

    How much free cash flow does DVA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.89B minus capital expenditures of $575.86M produced free cash flow of $1.31B.

    How much debt does DaVita HealthCare Partners have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $10.16B, short-term debt of $109.20M and cash and equivalents of $676.44M.